Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: The effects of taurine supplementation on oxidative stress indices and inflammation biomarkers in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

Fig. 2

Effects taurine supplementation on a superoxide dismutase (SOD) [reference value: 100–1600 μ/g Hb] b catalase (CAT) [reference value: 1.12–150 μ/mL] c malondialdehyde (MDA) [reference value: 0.38–133.33 nmol/mL], d total antioxidant capacity (TAC) [reference value: 0.049–2.5 mmol/L], e high-sensitivity C-reactive protein (hs-CRP) reference value: 0.10–500 mg/L], f tumor necrosis factor alpha (TNF‐α) [reference value: 3–900 ng/L] and g serum interleukin 6 (IL-6) [reference value: 2–600 ng/L]. Data were present as mean ± SE for taurine (n = 26) and placebo (n = 24) groups. P < 0.05 for within group comparisons (paired sample t test); *P < 0.05 for between group comparisons (ANCOVA adjusted for differences in baseline values, weight, and energy intake)

Back to article page